EN
Patient-first cell therapy innovation
 
Scientific Publication
  • 12.182018
    Local mutational diversity drives intratumoral immune heterogeneity in non-small cell lung cancer.
    Jia Q., Wu W., Wang Y., Alexander P.B., Sun C., Gong Z., Cheng J., Sun H., Guan Y., Xia X., Yang L., Yi X., Wan Y., Wang H., Futreal P.A., Li Q.-J.*, Zhu B.* (2018) Local mutational diversity drives intratumoral immune heterogeneity in non-small cell
  • 12.132018
    Late-stage tumors induce anemia and immunosuppressive extramedullary erythroid progenitor cells.
    Zhao L., He R., Long H., Guo B., Jia Q., Qin D., Liu S.-Q., Wang Z., Xiang T., Zhang J., Tan Y., Huang J., Chen J., Wang F., Xiao M., Gao J., Yang X., Zeng H., Wang X., Hu C., Alexander P. B., Symonds A.L.J., Yu J., Wan Y., Li Q.-J.*, Ye L.*, Zhu B
123
More

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer
About TCRCure
Research and Development
Products and Clinic
News and Media
Recruitment

Copyright © 2019 TCR CURE Biopharma Technology Co., Ltd Powered by vancheer